TC Biopharm (Holdings) Plc (TCBP)
$4.97
-0.15 (-2.93%)
Rating:
Recommendation:
-
| Symbol | TCBP |
|---|---|
| Price | $4.97 |
| Beta | 0.000 |
| Volume Avg. | 1.06M |
| Market Cap | 3.951M |
| Shares () | - |
| 52 Week Range | 2.81-175.0 |
| 1y Target Est | - |
| DCF Unlevered | TCBP DCF -> | |
|---|---|---|
| DCF Levered | TCBP LDCF -> | |
| ROE | 66.20% | Strong Buy |
| ROA | -38.47% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 1232.12% | Strong Buy |
| P/E | - | |
| P/B | 2 | Strong Buy |
Latest TCBP news
About
Download (Excel)TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.